ACE-031 1mg is a recombinant research protein studied for its interaction with signaling pathways associated with the transforming growth factor-beta (TGF-β) superfamily. Researchers investigate ACE-031 in controlled laboratory environments to better understand myostatin-related signaling, activin receptor pathways, and mechanisms involved in skeletal muscle biology.
Due to its ability to interact with receptor-mediated signaling pathways, ACE-031 has attracted scientific interest in research involving muscle biology, growth-factor signaling, protein interactions, and cellular regulation. Its research profile makes it a useful subject for controlled investigations into the molecular mechanisms governing muscle-related biological processes.
ACE-031 is a recombinant fusion protein designed for research into signaling pathways involving activin receptor type IIB (ActRIIB). Researchers study its interactions with members of the TGF-β superfamily to better understand receptor signaling and biological processes associated with skeletal muscle.
Laboratory investigations continue to examine ACE-031’s molecular characteristics, receptor interactions, and downstream signaling effects. These studies contribute to broader research into growth-factor biology, protein signaling, and cellular regulation.
Compound Type: Recombinant Research Protein
Research Focus: ActRIIB and TGF-β superfamily signaling research
Primary Function: Growth-factor and muscle biology research
ACE-031 is studied for its ability to interact with activin receptor type IIB (ActRIIB), a receptor involved in signaling pathways associated with several members of the TGF-β superfamily. Researchers investigate how modulation of these pathways affects downstream cellular signaling.
Laboratory studies focus on the molecular interactions between ACE-031 and relevant signaling proteins and receptors. This research helps scientists better understand the complex regulatory mechanisms involved in growth-factor signaling and skeletal muscle biology.
ACE-031 is commonly investigated in laboratory studies focused on:
Its distinctive recombinant protein structure makes ACE-031 relevant to scientific investigations involving receptor biology, muscle-related signaling, and growth-factor pathways.
ACE-031 has attracted research interest because of its relationship with ActRIIB-mediated signaling and the broader TGF-β superfamily. Researchers continue to examine its molecular interactions to better understand how these signaling pathways regulate cellular and tissue-level processes.
Ongoing laboratory investigations provide opportunities to study receptor-mediated signaling, protein interactions, and pathways associated with skeletal muscle biology. Further research may help clarify the molecular mechanisms underlying ACE-031 activity in experimental systems.
Product Name: ACE-031
Content: 1mg per vial
Quantity: 10 Vials
Form: Lyophilized Powder
Purity: ≥99%
Store in a cool, dry place away from direct sunlight, heat, and moisture to help maintain product stability and research-grade quality. Refrigeration may be appropriate according to established laboratory storage protocols. After reconstitution, follow applicable laboratory procedures and stability requirements for proper storage and handling.
Proper storage under controlled laboratory conditions can help preserve the integrity of the recombinant protein and support consistent experimental research. Always handle and store the product according to appropriate laboratory protocols and keep it in a secure environment intended for qualified research professionals.
ACE-031 is intended strictly for research and laboratory use only. It is not approved for human consumption, medical use, or therapeutic applications. This product is not intended to diagnose, treat, cure, or prevent any disease or condition. All handling and experimentation must be performed by qualified professionals in accordance with applicable laws, regulations, and institutional laboratory protocols.